The second-generation Palisade SUV, a full-change model after six years, has been available in the domestic market since January. LG CNS, an information technology affiliate of South Korea's LG ...

Cohen & Steers, Inc. is a publicly owned asset management holding company. Through its subsidiaries, the firm provides its services to institutional investors, including pension funds, endowments ...

After an initial 4–6 weeks of intravenous amphotericin B, transition to an oral azole agent to complete a minimum of 12 months of therapy is recommended, with voriconazole the preferred option for ...

Flying can feel like a scary proposition, even for seasoned travelers. But it's important to remember that several generations of very smart engineers have constructed extremely sturdy aircraft ...

Officials said the tornado destroyed two homes and several smaller structures, as well as numerous trees. One person was killed, and two others were injured. In Moore, at least two people ...

The "Messy" singer hilariously showed herself "twerking my way through the sickness" at the music festival in Indio, California Jack Irvin has over five years of experience working in digital ...

In the next 20 years, an astounding $84 trillion is expected to change hands as older Americans pass wealth down to younger generations. I'm 49 years old and have nothing saved for retirement ...

It's been a great year for RPGs so far between games like Kingdom Come: Deliverance 2, The First Berserker: Khazan, Avowed, and others, and what could stand out as one of 2025's best is fast ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. US President Donald Trump seems to be having a big impact on a small ski village in the Swiss Alps. In ...

Researchers have developed a CRISPR–Cas9-based epigenetic editing approach that sensitizes glioblastoma cells to standard chemotherapy drugs and could improve the treatment of tumours that have ...

Its preclinical candidate ATV:aSyn is a bispecific antibody designed to penetrate the central nervous system more effectively, with one end targeting alpha-synuclein and another targeting a ...

AbbVie has agreed to pay $65 million on an option deal with start-up Gilgamesh Pharma, lining up rights to neuroplastogen compounds that can improve neuroplasticity - the ability of the brain to ...